Listen: FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future
This week on "The Readout LOUD" podcast: Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.
What's Your Reaction?
